Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX

Abstract

To identify the best lipid nanoparticles for delivery of purified Cas9 protein and gRNA complexes (Cas9 RNPs) into mammalian cells and to establish the optimal conditions for transfection. Using a systematic approach, we screened 60 transfection reagents using six commonly-used mammalian cell lines and identified a novel transfection reagent (named Lipofectamine CRISPRMAX). Based on statistical analysis, the genome modification efficiencies in Lipofectamine CRISPRMAX-transfected cell lines were 40 or 15 % higher than those in Lipofectamine 3000 or RNAiMAX-transfected cell lines, respectively. Upon optimization of transfection conditions, we observed 85, 75 or 55 % genome editing efficiencies in HEK293FT cells, mouse ES cells, or human iPSCs, respectively. Furthermore, we were able to co-deliver donor DNA with Cas9 RNPs into a disrupted EmGFP stable cell line, resulting in the generation of up to 17 % EmGFP-positive cells. Lipofectamine CRISPRMAX was characterized as the best lipid nanoparticles for the delivery of Cas9 RNPs into a variety of mammalian cell lines, including mouse ES cells and iPSCs.

DOI: 10.1007/s10529-016-2064-9

Extracted Key Phrases

6 Figures and Tables

Cite this paper

@inproceedings{Yu2016ImprovedDO, title={Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX}, author={Xin Yu and Xiquan Liang and Huimin Xie and Shantanu Kumar and Namritha Ravinder and J. Potter and Xavier de Mollerat du Jeu and Jonathan D. Chesnut}, booktitle={Biotechnology Letters}, year={2016} }